DEPO-MEDROL susp inj 40 mg/ml 25 flac 1 ml
7680259150706
CH-25915
H02AB04
07.07.23
1 / 3
google
Details
- Product number
- 2591502
- CPT
- -
- Packaging group
- 25 x 1 mL
- Unit
- Durchstechflasche(n)
- Composition
- methylprednisoloni acetas 40 mg, macrogolum 3350, natrii chloridum, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, miripirii chloridum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 3.45 mg.
Articles (1)
Depo-Medrol 40 mg/mL, Injektionssuspension
Injektionssuspension
25 x 1 mL
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.45 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 111.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2020
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 25915
- Drug name
- Depo-Medrol, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- H02AB04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/05/1960
- Authorization expiration date
- 31/12/9999
- IT number
- 07.07.23
- Domain
- Human medicine
Packaging details
- Description (FR)
- DEPO-MEDROL susp inj 40 mg/ml 25 flac 1 ml
- Description (DE)
- DEPO-MEDROL Inj Susp 40 mg/ml 25 Durchstf 1 ml
- Market launch
- 25/05/1960
- Narcotic (BTM)
- No